Related Experiment Videos
[Status epilepticus in childhood]
I Pascual-Castroviejo1, A Martínez-Bermejo, S I Pascual-Pascual
1Servicio de Neurología Pediátrica, Hospital Universitario La Paz, Madrid.
Insights
Status epilepticus (SE) is a critical pediatric neurological emergency. Prompt treatment, including antiepileptic drugs and vital function support, is crucial for managing SE and reducing mortality.
Area of Science:
- Pediatric Neurology
- Emergency Medicine
- Clinical Neuroscience
Context:
- Status epilepticus (SE) is a frequent pediatric neurological emergency with significant mortality and morbidity.
- SE can occur in various contexts, including infections, epilepsy, malformations, hypoxia, hypoglycemia, and head trauma, or as a first unprovoked seizure.
- Non-convulsive SE, though less recognized, carries similar complications to convulsive SE.
Purpose:
- To outline the critical management strategies for pediatric status epilepticus (SE).
- To detail therapeutic options, including traditional and novel antiepileptic drugs (AEDs).
- To emphasize the importance of simultaneous diagnostic and therapeutic interventions.
Summary:
- SE management requires immediate attention to vital functions (ABCs) and prompt administration of appropriate AEDs.
- Treatment protocols for both initial and refractory SE are presented, highlighting drug choices, dosages, and administration routes.
- Mortality rates for SE in children range from 3-7%, with higher risks in refractory cases.
Impact:
- Provides essential guidance for clinicians managing pediatric SE emergencies.
- Contributes to improved patient outcomes by standardizing treatment approaches.
- Highlights the need for timely intervention to mitigate the high morbidity and mortality associated with SE.
Abstract:
Status epilepticus (SE) is one of the most common emergencies in pediatric neurology and it is associated with high mortality and morbidity. SE is more frequent in children than in adults. SE occurs in variety of settings especially in children-infections, patients with previously established epilepsy, cerebral malformations, hypoxia, hypoglucemia and head trauma- but in many cases SE can present as a first unprovoked seizures. Being better known the convulsive SE, non-convulsive SE that may present the same complications as the convulsive SE may be found in many patients. The mortality associated with SE in children is between 3 and 7%. The mortality and morbidity is estimated very high in the refractory SE. Although SE is defined as more than 30 min of continuous seizure activity, antiepileptic drug administration should be considered whenever a seizure has lasted 10 min. Initial therapeutic and etiological diagnostic have be conducted simultaneously. The commonest lines for treating SE and SE refractory are shown. The SE treatment should be managed including the ABCs of vital functions-supporting respiration, maintaining blood pressure, gaining access to circulation, electrolyte levels, renal and hepatic functioning and glucose levels- as well as a prompt administration of appropriate drugs in adequate doses. The different antiepileptic drugs that can be administered to the SE treatment are presented as well as the pharmacologic peculiarities, route of choice for drug administration, doses and risks of the traditional and the new antiepileptic drugs.